PR: Advertising by Other Means

Al and Laura Ries make several arguments in their book The Fall of Advertising & The Rise of PR to support their claim that PR builds brands whereas advertising merely serves to defend the brand. This article provides real world pharmaceutical examples in support of the Ries's claims.

2nd Annual Drug Repurposing and Repositioning

This conference will focus on identifying suitable compounds and opportunities for repurposing.

PR Marketing: Mystery Wrapped in a Riddle

Yesterday's post, "Marketing Disguised as PR", generated some interesting counterpoints and comments from friends in the blogosphere and on the PHARMA-MKTING discussion forum. Seems...

Marketing Disguised as PR

Public Relations (PR) is not just for managing a company's image and for damage control. It's also used as an adjunct to marketing products...

AMA vs DTC: Spinmeisters at Work

The American Medical Association recently called for an FDA-mandated moratorium on direct-to-consumer (DTC) drug ads and left it up to the industry and FDA...

CME: Promotion vs Education

Pharmaceutical companies provide over half the financial support and funding for continuing medical education (CME) programs. In 2004, the industry spent over $1 Billion...

Fat Acomplia?

Occasionally, I predict the next frontier in pharmaceutical marketing. Back in September, 2005, for example, I predicted that "sleep aid" DTC (direct-to-consumer) advertising would...

Two Sources of Zocor

As reported in the Philadelphia Inquirer:"This week, Merck & Co. Inc.'s patent on the No. 2 cholesterol drug Zocor will expire, clearing the way...

2nd Annual Medical Device and Diagnostics Marketing Compliance Congress

Critical Updates on Enforcement Actions, Criminal and Civil Liability and Compliance Tactics Regarding Advertising, Off-Label Promotion and Fraud & Abuse

2nd Annual Medical Device and Diagnostics Marketing Compliance Congress

Critical Updates on Enforcement Actions, Criminal and Civil Liability and Compliance Tactics Regarding Advertising, Off-Label Promotion and Fraud & Abuse